Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 7:06 pm Purchase |
2025-02-10 | 13G | OncoCyte Corporation OCX |
BIO RAD LABORATORIES INC BIO |
2,764,078 9.700% |
1,253,134 (+82.94%) |
Filing History |
| 2025-02-14 2:41 pm Purchase |
2024-12-31 | 13G | OncoCyte Corporation OCX |
AWM Investment Company, Inc. | 1,306,309 7.500% |
1,306,309 (New Position) |
Filing History |
| 2025-02-10 8:46 pm Purchase |
2025-02-06 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 11,560,350 40.200% |
6,481,034 (+127.60%) |
Filing History |
| 2024-12-27 9:58 pm Purchase |
2024-12-26 | 13G | OncoCyte Corporation OCX |
SMITH PATRICK W | 1,773,903 10.500% |
215,466 (+13.83%) |
Filing History |
| 2024-12-09 5:30 pm Purchase |
2024-12-05 | 13G | OncoCyte Corporation OCX |
SMITH PATRICK W | 1,558,437 9.300% |
545,116 (+53.79%) |
Filing History |
| 2024-11-14 1:26 pm Sale |
2024-11-14 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 616,587 4.570% |
-91,585 (-12.93%) |
Filing History |
| 2024-10-24 12:13 pm Purchase |
2024-10-04 | 13G | OncoCyte Corporation OCX |
BIO RAD LABORATORIES INC BIO |
1,510,944 8.970% |
1,510,944 (New Position) |
Filing History |
| 2024-10-09 5:03 pm Purchase |
2024-10-02 | 13G | OncoCyte Corporation OCX |
SMITH PATRICK W | 1,013,321 6.000% |
1,013,321 (New Position) |
Filing History |
| 2024-04-22 1:30 pm Purchase |
2024-04-15 | 13G | Bio-Rad Laboratories, Inc. BIO |
BIO RAD LABORATORIES INC BIO |
1,200,109 8.990% |
1,200,109 (New Position) |
Filing History |
| 2024-04-15 7:26 pm Purchase |
2024-04-11 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 5,079,316 37.600% |
5,079,316 (New Position) |
Filing History |
| 2024-02-14 5:03 pm Sale |
2023-12-31 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 708,172 8.450% |
-123,919 (-14.89%) |
Filing History |
| 2024-02-14 3:47 pm Purchase |
2023-12-31 | 13G | OncoCyte Corporation OCX |
AWM Investment Company, Inc. | 754,286 9.100% |
391,575 (+107.96%) |
Filing History |
| 2023-04-14 4:31 pm Sale |
2023-04-14 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 832,091 9.990% |
-70,723 (-7.83%) |
Filing History |
| 2023-04-07 10:38 am Purchase |
2023-04-03 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 2,856,559 33.300% |
1,345,914 (+89.10%) |
Filing History |
| 2023-02-14 1:11 pm Unchanged |
2022-12-31 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 902,814 15.220% |
0 (Unchanged) |
Filing History |
| 2023-02-14 11:33 am Purchase |
2022-12-31 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 902,814 15.220% |
291,616 (+47.71%) |
Filing History |
| 2023-02-14 11:23 am Purchase |
2022-12-31 | 13G | OncoCyte Corporation OCX |
AWM Investment Company, Inc. | 362,711 6.100% |
362,711 (New Position) |
Filing History |
| 2022-11-23 5:52 pm Purchase |
2022-11-11 | 13G | OncoCyte Corporation OCX |
Norfield Capital LLC | 330,018 5.500% |
330,018 (New Position) |
Filing History |
| 2022-07-28 5:06 pm Purchase |
2022-07-21 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 1,510,645 24.100% |
321,897 (+27.08%) |
Filing History |
| 2022-05-09 3:23 pm Purchase |
2022-04-30 | 13G | OncoCyte Corporation OCX |
BLACKROCK INC BLK |
250,261 4.200% |
604 (+0.24%) |
Filing History |